{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T21:00:22Z","timestamp":1777669222313,"version":"3.51.4"},"reference-count":41,"publisher":"SAGE Publications","issue":"6","license":[{"start":{"date-parts":[[1990,11,1]],"date-time":"1990-11-01T00:00:00Z","timestamp":657417600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hum Exp Toxicol"],"published-print":{"date-parts":[[1990,11]]},"abstract":"<jats:p>1 The metabolism of aspirin was investigated in 45 patients who had taken self-administered overdose of aspirin and were treated with fluids only, glycine, N-glycylglycine by mouth, or by sodium bicarbonate i.v.<\/jats:p>\n                  <jats:p>2 The major metabolite recovered in the urine of patients treated with oral fluids, glycine or N-glycylglycine was salicyluric acid, which accounted for means of 51%, 47% and 38% of the total, respectively; salicylic acid comprised 19%, 29% and 29%. In contrast, salicylic acid (42%) was the major urinary metabolite recovered from patients treated with sodium bicarbonate.<\/jats:p>\n                  <jats:p>3 Plasma glycine concentrations in healthy volunteers who had taken no aspirin remained constant through the day and were not affected by a therapeutic dose (500 mg) of aspirin. Plasma glycine was consistently lower in patients with aspirin overdose than in these healthy volunteers, suggesting depletion of available glycine.<\/jats:p>\n                  <jats:p>4 Orally administered glycine and N-glycylglycine increased plasma glycine. While the fraction of total salicylate recovered as salicyluric acid was not altered, the maximum rate of excretion of salicyluric acid was higher in patients who received glycine than in the control group; there was no significant difference in the maximum rate of excretion of salicyluric acid between the group that received glycine and the group that received N-glycylglycine. 5 The data suggest that exogenous glycine increases the rate of formation of salicyluric acid in salicylate overdose.<\/jats:p>","DOI":"10.1177\/096032719000900606","type":"journal-article","created":{"date-parts":[[2008,12,24]],"date-time":"2008-12-24T01:08:04Z","timestamp":1230080884000},"page":"389-395","source":"Crossref","is-referenced-by-count":16,"title":["Depletion of Plasma Glycine and Effect of Glycine by Mouth on Salicylate Metabolism During Aspirin Overdose"],"prefix":"10.1177","volume":"9","author":[{"given":"D.K.","family":"Patel","sequence":"first","affiliation":[{"name":"Medicinal Biochemistry Department, Burroughs Wellcome Co., 3030 Cornwallis Road, Research Triangle Park, NC 27709, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Ogunbona","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Ife, Ile Ife, Nigeria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.J.","family":"Notarianni","sequence":"additional","affiliation":[{"name":"Schools of Pharmacy and Pharmacology and Postgraduate Medicine, University of Bath, Bath, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.N.","family":"Bennett","sequence":"additional","affiliation":[{"name":"Clinical Pharmacology Unit, Royal United Hospital, Bath, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[1990,11,1]]},"reference":[{"key":"atypb1","doi-asserted-by":"publisher","DOI":"10.1177\/096032718100100102"},{"key":"atypb2","doi-asserted-by":"publisher","DOI":"10.1016\/0735-6757(86)90220-2"},{"key":"atypb3","first-page":"104","volume":"6","author":"Veltri JC","year":"1988","journal-title":"Emergency Medicine"},{"key":"atypb4","first-page":"364","volume":"141","author":"Temple AR","year":"1981","journal-title":"Internal Medicine"},{"key":"atypb5","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.289.6448.820"},{"key":"atypb6","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.289.6451.1039-a"},{"key":"atypb7","doi-asserted-by":"publisher","DOI":"10.3928\/0090-4481-19871101-08"},{"key":"atypb8","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.285.6352.1383"},{"key":"atypb9","first-page":"61","volume":"9","author":"Temple AR","year":"1976","journal-title":"Toxicology"},{"key":"atypb10","doi-asserted-by":"crossref","unstructured":"Kimberly RP & Plotz PH Aspirin-induced depression of renal function. New England Journal of Medicine, 1977; 296: 418-24.","DOI":"10.1056\/NEJM197702242960803"},{"key":"atypb11","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-94-3-317"},{"key":"atypb12","first-page":"E606","volume":"234","author":"Spenney JG","year":"1978","journal-title":"American Journal of Physiology"},{"key":"atypb13","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S0022-3565(25)21674-3","volume":"226","author":"Ali B.","year":"1983","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"atypb14","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780270409"},{"key":"atypb15","doi-asserted-by":"publisher","DOI":"10.3109\/03602537909046431"},{"key":"atypb16","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1985.tb02695.x"},{"key":"atypb17","doi-asserted-by":"publisher","DOI":"10.3109\/00498258609043527"},{"key":"atypb18","first-page":"587P","volume":"15","author":"Notarianni LJ","year":"1983","journal-title":"British Journal of Clinical Pharmacology"},{"key":"atypb19","doi-asserted-by":"publisher","DOI":"10.1177\/096032719000900302"},{"key":"atypb20","doi-asserted-by":"publisher","DOI":"10.1002\/jps.2600580432"},{"key":"atypb21","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1981.158"},{"key":"atypb22","doi-asserted-by":"publisher","DOI":"10.1002\/jps.2600580307"},{"key":"atypb23","doi-asserted-by":"publisher","DOI":"10.1042\/bj0570301"},{"key":"atypb24","doi-asserted-by":"publisher","DOI":"10.1093\/clinchem\/26.1.111"},{"key":"atypb25","first-page":"418","volume":"24","author":"Bedford C.","year":"1965","journal-title":"British Journal of Pharmacology"},{"key":"atypb26","doi-asserted-by":"publisher","DOI":"10.1002\/jps.2600540703"},{"key":"atypb27","doi-asserted-by":"publisher","DOI":"10.1002\/jps.2600580705"},{"key":"atypb28","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(70)90335-7"},{"key":"atypb29","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0026-895X(25)12659-X","volume":"7","author":"Forman WB","year":"1971","journal-title":"Molecular Pharmacology"},{"key":"atypb30","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1980.tb04816.x"},{"key":"atypb31","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0022-3565(25)27374-8","volume":"153","author":"Nelson E.","year":"1966","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"atypb32","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(66)90267-X"},{"key":"atypb33","doi-asserted-by":"publisher","DOI":"10.1136\/gut.9.4.425"},{"key":"atypb34","doi-asserted-by":"publisher","DOI":"10.1172\/JCI106724"},{"key":"atypb35","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-198308030-00005"},{"key":"atypb36","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197208312870903"},{"key":"atypb37","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1172\/JCI108766","volume":"60","author":"Furst DE","year":"1977","journal-title":"Journal of Clinical Investigation"},{"key":"atypb38","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0090-9556(25)00279-X","volume":"8","author":"Bekersky I.","year":"1980","journal-title":"Drug Metabolism and Disposition"},{"key":"atypb39","doi-asserted-by":"publisher","DOI":"10.1038\/200139a0"},{"key":"atypb40","first-page":"252","volume":"5","author":"Quastel JH","year":"1963","journal-title":"Applied Therapeutics"},{"key":"atypb41","volume-title":"Aspirin and the salicylates","author":"Rainsford KD","year":"1984"}],"container-title":["Human &amp; Experimental Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/096032719000900606","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/096032719000900606","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T07:52:22Z","timestamp":1777449142000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/096032719000900606"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1990,11]]},"references-count":41,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1990,11]]}},"alternative-id":["10.1177\/096032719000900606"],"URL":"https:\/\/doi.org\/10.1177\/096032719000900606","relation":{},"ISSN":["0960-3271","1477-0903"],"issn-type":[{"value":"0960-3271","type":"print"},{"value":"1477-0903","type":"electronic"}],"subject":[],"published":{"date-parts":[[1990,11]]}}}